Last week's biggest headline deals occupied the fields of cancer and dementia, while a host of smaller deals included several targeting infectious diseases affecting developing countries, and vaccine and manufacturing technologies were much in evidence.
Scrip's new regular round-up of the week's partnership and M&A news reveals that for the week from 10 November to 16 November, the total disclosed value of agreements amounted to...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?